BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 30, 2009
View Archived Issues
Odanacatib increases BMD in ovariectomized monkeys and postmenopausal women
Read More
EMEA approves ALK-Abello's Grazax as disease-modifying allergy treatment
Read More
Achillion completes phase Ia of phase Ia/b clinical trial of ACH-1625 in hepatitis C
Read More
Antitumor effect of TH-302 plus gemcitabine, docetaxel or pemetrexed seen in phase Ib trial
Read More
MT-110 safe and biologically active in phase I advanced solid tumors trial
Read More
Taisho claims mgluR5 agonists for the treatment of psychiatric disorders
Read More
Glucokinase activators for the treatment of diabetes disclosed by Daiichi Sankyo
Read More
Sanofi-aventis completes enrollment in phase III angiogenesis trial of NV1-FGF
Read More
European CHMP issues positive opinion for Januvia and Janumet for type 2 diabetes
Read More
Boehringer concludes phase III clinical trials of linagliptin in type 2 diabetes
Read More
European CHMP issues positive opinion for Pandemrix, GSK's pandemic H1N1 vaccine
Read More
Addex completes enrollment in phase IIb trial in gastroesophageal reflux disease
Read More
NCI awards phase II bridge grant to Altor BioScience to develop ALT-801
Read More
Wyeth's pneumococcal vaccine Prevenar 13 receives positive opinion for E.U. approval
Read More
Novartis' QAB-149 recommended for approval in the E.U. for treatment of COPD
Read More
European CHMP issues positive opinion for sanofi-aventis' Multaq in atrial fibrillation
Read More
Momenta reports results from EMINENCE phase II trial of anticoagulant M-118
Read More
University of Texas initiates enrollment in phase II trial of Oncolytics Biotech's Reolysin
Read More
PM-181104 shows antimicrobial activity in mouse models of MRSA and VRE infections
Read More
Hib-MenCY-TT candidate vaccine is immunogenic and well tolerated as 4th dose in infants
Read More
Synthetic vaccine SFV2/NAM1 displays broadly reactive immunity against influenza
Read More
HVJ envelope to enter clinical study for melanoma
Read More
Vitae Pharmaceuticals discovers 11beta-HSD1 inhibitors for the treatment of obesity
Read More
NS5B inhibitors for the treatment of HCV infection identified by Roche
Read More
AstraZeneca granted approval for Seroquel XR and Seroquel in Europe for bipolar disorder
Read More
Sciele submits NDA to FDA for glycopyrrolate to treat drooling in pediatric patients
Read More